OFS
SAGE

OneAscent Financial Services’s Sage Therapeutics SAGE Stock Holding History

OneAscent Financial Services’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-7,531
Closed -$216K – 187
2020
Q1 		$216K Buy
+7,531
New +$436K 0.16% 126
2019
Q3 		– Sell
-2,206
Closed -$404K – 151
2019
Q2 		$404K Buy
+2,206
New +$376K 0.28% 74

Other funds holding SAGE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

OneAscent Financial Services's SAGE Position: Q2 2020 in Review

OneAscent Financial Services sold out of Sage Therapeutics (SAGE) in Q2 2020, closing a stake of 7,531 shares — an estimated $216K sold.

OneAscent Financial Services first reported a position in SAGE in Q2 2019 and held it in 2 quarters. The position peaked at $404K in Q2 2019. 217 funds tracked by Wall St. Rank hold SAGE as of Q2 2020.

  • OneAscent Financial Services reported no remaining Sage Therapeutics position as of Q2 2020 after selling out during the quarter.
  • OneAscent Financial Services sold 7,531 Sage Therapeutics shares in Q2 2020, an estimated $216K.
  • OneAscent Financial Services first reported a position in Sage Therapeutics in Q2 2019 and held it in 2 quarters.
  • OneAscent Financial Services's Sage Therapeutics position peaked at $404K in Q2 2019.
  • 217 funds tracked by Wall St. Rank held Sage Therapeutics as of Q2 2020.

Based on OneAscent Financial Services's 13F filing for Q2 2020, filed 21 Jul 2020.